PHARNEXT

CINGILVIA

Medicines for the treatment of rare neurodegenerative diseases; pharmaceutical products for the treatment of rare neurodegenerative diseases; pharmaceutical preparations for the treatment of rare neurodegenerative diseases; medical preparations for the treatment of rare neurodegenerative diseases; biological preparations for medical use for the treatment of rare neurodegenerative diseases;

ORPHANEXT

Training services; publication of books and texts other than advertising texts; electronic publication of texts in the field of pharmaceutical research and development, scientific research regarding medicine, online medicine; organization and conducting of colloquiums, conferences, congresses, seminars in the pharmaceutical and medical sector; teaching; information and awareness program on the treatment of diseases (education services);Compilation and management of databases and central data files in the field of pharmaceutical research and development, scientific research relating to medicine, medicine and clinical trials; compilation of statistics; collection and systematization of data in a central file; public relations;Providing information relating to pharmaceutical products in the field of pharmaceutical products and clinical trials;Pharmaceutical research and development; scientific research regarding medicine; conducting of clinical trials and studies; chemical and biological analysis; research in chemistry, cosmetology, biology, bacteriology, nutrition and biotechnology; biological research for the diagnosis, prevention and treatment of neurodegenerative, metabolic, inflammatory, cancerous and cardiac diseases, diabetes and obesity and any other diseases; biological research services in the field of chemical, biological and pharmaceutical products; design and development of software; scientific laboratory services; scientific research for chemical reagents for medical use, namely, biomarkers; creation (design) of databases and central data files in the field of pharmaceutical research and development, scientific research relating to medicine, medicine and clinical trials; providing information relating to medical and scientific research in the field of pharmaceutical products and clinical trials;

PHARNEXT

The mark consists of the stylized word PHARNEXT.;Biological preparations for medical purposes, medicines, namely, medicines for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis; pharmaceutical preparations for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis;PHARMACEUTICAL NEXT;Color is not claimed as a feature of the mark.;Building, compiling and managing databases, namely, electronic data collection and data submission services for business purposes in the field of medicine; compiling and managing computerised databases and central computerised data files in the field of medicine;[ Medical services ];Medical and scientific research in the field of medicine; biological research;